Investor meeting
November 13, 2025

Isofol invited to an investor meeting to provide an update on the company’s ongoing clinical study with the drug candidate arfolitixorin. The meeting was held in Gothenburg but can also be followed online. The presentation was held mainly in Swedish and can also be viewed afterwards via the link below.

Watch the webcast